Multi-Step Usage of in Vivo Models During Rational Drug Design and Discovery
Open Access
- 1 April 2011
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 12 (4) , 2262-2274
Abstract
In this article we propose a systematic development method for rational drug design while reviewing paradigms in industry, emerging techniques and technologies in the field. Although the process of drug development today has been accelerated by emergence of computational methodologies, it is a herculean challenge requiring exorbitant resources; and often fails to yield clinically viable results. The current paradigm of target based drug design is often misguided and tends to yield compounds that have poor absorption, distribution, metabolism, and excretion, toxicology (ADMET) properties. Therefore, an in vivo organism based approach allowing for a multidisciplinary inquiry into potent and selective molecules is an excellent place to begin rational drug design. We will review how organisms like the zebrafish and Caenorhabditis elegans can not only be starting points, but can be used at various steps of the drug development process from target identification to pre-clinical trial models. This systems biology based approach paired with the power of computational biology; genetics and developmental biology provide a methodological framework to avoid the pitfalls of traditional target based drug design.Keywords
This publication has 61 references indexed in Scilit:
- Cardiac Induction of Embryonic Stem Cells by a Small Molecule Inhibitor of Wnt/β-Catenin SignalingACS Chemical Biology, 2010
- Hedgehog signaling induces arterial endothelial cell formation by repressing venous cell fateDevelopmental Biology, 2010
- Sox10 is necessary for oligodendrocyte survival following axon wrappingGlia, 2010
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences, 2009
- In Vivo Structure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP InhibitorsACS Chemical Biology, 2009
- Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineagesNature Chemical Biology, 2009
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- A Phenotypic Small-Molecule Screen Identifies an Orphan Ligand-Receptor Pair that Regulates Neural Stem Cell DifferentiationChemistry & Biology, 2007
- In vivo drug discovery in the zebrafishNature Reviews Drug Discovery, 2005
- Finishing the euchromatic sequence of the human genomeNature, 2004